JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rady, J. J.
Right arrow Articles by Fujimoto, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rady, J. J.
Right arrow Articles by Fujimoto, J. M.

Vol. 296, Issue 1, 7-14, January 2001

Antianalgesic Action of Nociceptin Originating in the Brain Is Mediated by Spinal Prostaglandin E2 in Mice

Jodie J. Rady , William B. Campbell and James M. Fujimoto

Research Service, Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin (J.J.R., J.M.F.); and Department of Pharmacology, Medical College of Wisconsin, Milwaukee, Wisconsin (J.J.R., W.B.C., J.M.F.)

An antianalgesic action of intracerebroventricularly administered nociceptin was elicited against intrathecal morphine-induced antinociception in the tail-flick test in mice and investigated as a descending neuronal system for the spinal mediator involved. The nociceptin-induced antianalgesia originating in the brain was inhibited by intrathecally administered indomethacin and suggested the mediation of spinal prostaglandin. The antianalgesic action of intracerebroventricular nociceptin was closely matched by intrathecal prostaglandin (PG) E2. Both shifted the dose-response curve of morphine to the right and these actions were eliminated by intrathecal PGD2. Desensitization of the antianalgesic action of PGE2 by intrathecal PGE2 pretreatment also produced cross-desensitization to the antianalgesic action of intracerebroventricular nociceptin. Neither intracerebroventricular nociceptin nor intrathecal PGE2 produced antianalgesia against the delta -receptor agonists given intrathecally. Thus, the antianalgesic action of nociceptin originating in the brain is coupled to a descending neuronal pathway mediated by spinal PGE2.


0022-3565/01/2961-0007$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by U.S. Government



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. J. Rady and J. M. Fujimoto
Confluence of Antianalgesic Action of Diverse Agents through Brain Interleukin1beta in Mice
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 659 - 665.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. S. Mogil and G. W. Pasternak
The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family
Pharmacol. Rev., September 1, 2001; 53(3): 381 - 415.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.